LIGAND PHARMACEUTICALS INC (LGND)
Pharmaceutical Preparations
Latest Price
$287.54
TTM P/E
37.49
Normalized P/E
204.77
Div Yield
--
Book Value
50.16
P/B Ratio
5.73
Valuation metrics
adjust assumptions →EPS: $6.13
Book value / share: $51.44
Formula: √(22.5 × EPS × BVPS)
Graham Number
$84.23
71% downside
Norm. op. income: $26M (median of 7yr)
Tax rate: 21%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$47.42
84% downside
Base FCF: $70M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$300.69
+5% upside
EPS: $6.13
Target P/E: 37×
Formula: EPS × P/E
P/E Fair Value
$226.81
21% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.96M | $591.0M | 14.79% | +21.7K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.10M | $219.0M | 5.49% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 1.01M | $201.0M | 5.04% | +14.5K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 848.1K | $169.0M | 4.23% | -- | 2026-03-31 |
| Invesco Ltd. | 823.6K | $164.0M | 4.11% | +307.1K | 2026-03-31 |
| STATE STREET CORP | 778.9K | $155.0M | 3.89% | +27.7K | 2026-03-31 |
| FMR LLC | 596.1K | $119.0M | 2.98% | +17.0K | 2026-03-31 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 573.3K | $114.0M | 2.86% | -- | 2026-03-31 |
| FRANKLIN RESOURCES INC | 573.2K | $114.0M | 2.86% | +77.0K | 2026-03-31 |
| Chicago Capital, LLC | 561.7K | $112.0M | 2.80% | +252 | 2026-03-31 |